Naphthalene

Naphthalene

SCHEMBL7417075

CC(=O)OCC(=O)C(CC(=O)O)NC(=O)C(C)CC(=O)NCCc1ccccc1.c1ccc2ccccc2c1

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 5/20 0.51
CASP6 P55212 3/20 0.51
CASP8 Q14790 3/20 0.51
CASP1 P29466 13/20 0.45
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Naphthalene SCHEMBL8059816 0.90 CASP1 (0.52) CASP3CASP6CASP8CASP1
SCHEMBL7417068 0.84 CASP1 (0.64) CASP3CASP6CASP8CASP1HPGD
Naphthalene SCHEMBL8059861 0.83 CASP1 (0.46) CASP3CASP6CASP8CASP1
Naphthalene SCHEMBL8055399 0.82 CASP3 (0.45) CASP3CASP6CASP8CASP1
Naphthalene SCHEMBL8414586 0.82 CASP1 (0.52) CASP3CASP6CASP8CASP1
SCHEMBL6160794 0.82 KMT2A (0.51) CASP3CASP6CASP8CASP1ITGB3
Naphthalene SCHEMBL7423275 0.82 CASP1 (0.45) CASP3CASP6CASP8CASP1
Naphthalene SCHEMBL8412276 0.81 CASP1 (0.58) CASP1
Naphthalene SCHEMBL7421743 0.81 CASP1 (0.48) CASP3CASP6CASP8CASP1
Naphthalene SCHEMBL8414700 0.80 CASP1 (0.46) CASP3CASP6CASP8CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0932598-A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME WARNER-LAMBERT COMPANY (US) 1999-08-04 EP claimed
WO-1998016502-A1 ASPARTATE ESTER INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME WARNER-LAMBERT COMPANY (US) 1998-04-23 WO claimed
WO-2001019373-A2 METHODS AND COMPOSITIONS FOR MODULATING RESPONSIVENESS TO CORTICOSTEROIDS BASF AKTIENGESELLSCHAFT (DE) 2001-03-22 WO disclosed